A major role for RCAN1 in atherosclerosis progression

EMBO Molecular Medicine

Volumn 5, Issue 12, 2013, Pages 1901-1917

  Méndez Barbero, Nerea ^a   Esteban, Vanesa ^a   Villahoz, Silvia ^a   Escolano, Amelia ^a   Urso, Katia ^a   Alfranca, Arantzazu ^b   Rodríguez, Cristina ^c   Sánchez, Susana A ^a,f   Osawa, Tsuyoshi ^d   Andrés, Vicente ^a   Martínez González, José ^c   Minami, Takashi ^d   Redondo, Juan Miguel ^a   Campanero, Miguel R ^e  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Institut Català de Ciències Cardiovasculars   (Spain)

^d UNIVERSITY OF TOKYO   (Japan)

^e INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^f UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Atherosclerosis; Hypercholesterolemia; Inflammation; Macrophage; RCAN1

Indexed keywords

CD36 ANTIGEN; GELATINASE A; GELATINASE B; INTERLEUKIN 10; MANNOSE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN; PROTEIN RCAN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; AORTA ARCH; AORTA SINUS; AORTA VALVE DISEASE; ARTICLE; ASCENDING AORTA; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; GENE INACTIVATION; GENOTYPE; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; LIPID STORAGE; MACROPHAGE; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; INFLAMMATION; MACROPHAGE; RCAN1;

ANEURYSM; ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FOAM CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; PHENOTYPE;

EID: 84897005459     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201302842     Document Type: Article

References (54)

1. Abbasi S, Lee JD, Su B, Chen X, Alcon JL, Yang J, Kellems RE, Xia Y (2006) Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J Biol Chem 281: 7717-7726
2. Angeli V, Llodra J, Rong JX, Satoh K, Ishii S, Shimizu T, Fisher EA, Randolph GJ (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21: 561-574
3. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T et al (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130
4. Bagatolli LA, Sanchez SA, Hazlett T, Gratton E (2003) Giant vesicles, Laurdan, and two-photon fluorescence microscopy: Evidence of lipid lateral separation in bilayers. Methods Enzymol 360: 481-500
5. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N et al (2007) PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6: 137-143
6. Cano E, Canellada A, Minami T, Iglesias T, Redondo JM (2005) Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. J Biol Chem 280: 29435-29443
7. Chase AJ, Bond M, Crook MF, Newby AC (2002) Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol 22: 765-771
8. Cho YJ, Abe M, Kim SY, Sato Y (2005) Raf-1 is a binding partner of DSCR1. Arch Biochem Biophys 439: 121-128
9. Crawford DR, Leahy KP, Abramova N, Lan L, Wang Y, Davies KJ (1997) Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. Arch Biochem Biophys 342: 6-12
10. Davies KJ, Ermak G, Rothermel BA, Pritchard M, Heitman J, Ahnn J, Henrique-Silva F, Crawford D, Canaider S, Strippoli P et al (2007) Renaming the DSCR1/Adapt78 gene family as RCAN: Regulators of calcineurin. FASEB J 21: 3023-3028
11. Ermak G, Harris CD, Battocchio D, Davies KJ (2006) RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta. FEBS J 273: 2100-2109
12. Ermak G, Harris CD, Davies KJ (2002) The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB J 16: 814-824
13. Espinosa AV, Shinohara M, Porchia LM, Chung YJ, McCarty S, Saji M, Ringel MD (2009) Regulator of calcineurin 1 modulates cancer cell migration in vitro. Clin Exp Metastasis 26: 517-526
14. Esteban V, Mendez-Barbero N, Jimenez-Borreguero LJ, Roque M, Novensa L, Garcia-Redondo AB, Salaices M, Vila L, Arbones ML, Campanero MR et al (2011) Regulator of calcineurin 1 mediates pathological vascular wall remodeling. J Exp Med 208: 2125-2139
15. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056
16. Ferretti G, Rabini RA, Bacchetti T, Vignini A, Salvolini E, Ravaglia F, Curatola G, Mazzanti L (2002) Glycated low density lipoproteins modify platelet properties: A compositional and functional study. J Clin Endocrinol Metab 87: 2180-2184
17. Fuentes JJ, Pritchard MA, Estivill X (1997) Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44: 358-361
18. Getz GS, Reardon CA (2012) Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 32: 1104-1115
19. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964
20. Greaves DR, Gordon S (2009) The macrophage scavenger receptor at 30 years of age: Current knowledge and future challenges. J Lipid Res 50: S282-286
21. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12: 204-212
22. Harris CD, Ermak G, Davies KJ (2005) Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. Cell Mol Life Sci 62: 2477-2486
23. Hoeffer CA, Dey A, Sachan N, Wong H, Patterson RJ, Shelton JM, Richardson JA, Klann E, Rothermel BA (2007) The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J Neurosci 27: 13161-13172
24. Iizuka M, Abe M, Shiiba K, Sasaki I, Sato Y (2004) Down syndrome candidate region 1, a downstream target of VEGF, participates in endothelial cell migration and angiogenesis. J Vasc Res 41: 334-344
25. Kadl A, Meher AK, Sharma PR, Lee MY, Doran AC, Johnstone SR, Elliott MR, Gruber F, Han J, Chen W et al (2010) Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 107: 737-746
26. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, Clement M, Dussiot M, Levillain O, Graff-Dubois S, Nicoletti A et al (2010) Macrophage plasticity in experimental atherosclerosis. PLoS One 5: e8852
27. Kingsbury TJ, Cunningham KW (2000) A conserved family of calcineurin regulators. Genes Dev 14: 1595-1604
28. Lapid K, Itkin T, D'Uva G, Ovadya Y, Ludin A, Caglio G, Kalinkovich A, Golan K, Porat Z, Zollo M et al (2013) GSK3beta regulates physiological migration of stem/progenitor cells via cytoskeletal rearrangement. J Clin Invest 123: 1705-1717
29. Lee EJ, Seo SR, Um JW, Park J, Oh Y, Chung KC (2008) NF-kappaB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1. J Biol Chem 283: 3392-3400
30. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874
31. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C et al (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85: e17-24
32. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T et al (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279: 50537-50554
33. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969
34. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140
35. Park YM, Febbraio M, Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119: 136-145
36. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353
37. Porta S, Serra SA, Huch M, Valverde MA, Llorens F, Estivill X, Arbones ML, Marti E (2007) RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: A potential pathogenic process in neurodegeneration. Hum Mol Genet 16: 1039-1050
38. Randolph GJ (2008) Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis. Curr Opin Lipidol 19: 462-468
39. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275: 8719-8725
40. Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13: 420-431
41. Sanchez SA, Tricerri MA, Gunther G, Gratton E, (2007) Laurdan generalized polarization: From cuvette to microscope. In Modern Research and Educational Topics in Microscopy: Applications in Physical/Chemical Sciences, Mendez-Vilas A, Diaz J (eds), pp 1007-1014. Badajoz, Spain: Formatex
42. Sanchez S. A, Tricerri MA, Ossato G, Gratton E (2010) Lipid packing determines protein-membrane interactions: Challenges for apolipoprotein A-I and high density lipoproteins. Biochim Biophys Acta 1798: 1399-1408
43. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr., Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb 14: 840-856
44. Stossel TP (1994) The machinery of cell crawling. Sci Am 271: 54-55, 58-63
45. Strippoli P, Petrini M, Lenzi L, Carinci P, Zannotti M (2000) The murine DSCR1-like (Down syndrome candidate region 1) gene family: Conserved synteny with the human orthologous genes. Gene 257: 223-232
46. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T et al (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296
47. van Tits LJ, Stienstra R, van Lent PL, Netea MG, Joosten LA, Stalenhoef AF (2011) Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Kruppel-like factor 2. Atherosclerosis 214: 345-349
48. Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, Bassel-Duby R, Williams RS, Olson EN (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci USA 100: 669-674
49. Waldo SW, Li Y, Buono C, Zhao B, Billings EM, Chang J, Kruth HS (2008) Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol 172: 1112-1126
50. Wang Y, De Keulenaer GW, Weinberg EO, Muangman S, Gualberto A, Landschulz KT, Turi TG, Thompson JF, Lee RT (2002) Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes. Am J Physiol Heart Circ Physiol. 283: H533-539
51. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: Subsets and functions. Nat Rev Cardiol 7: 77-86
52. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS (2000) Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87: E61-68
53. Yang YJ, Chen W, Edgar A, Li B, Molkentin JD, Berman JN, Lin TJ (2009) Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function. J Exp Med 206: 195-207
54. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471